HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Karl Storz Acquires British AI Specialist Innersight Labs

By HospiMedica International staff writers
Posted on 11 Jan 2024
Print article
Image: KARL STORZ and Innersight Labs have combined forces to push AI solutions for healthcare (Photo courtesy of Business Wire)
Image: KARL STORZ and Innersight Labs have combined forces to push AI solutions for healthcare (Photo courtesy of Business Wire)

KARL STORZ (Tuttlingen, Germany), a family-owned MedTech company, has acquired Innersight Labs Ltd. (ISL, London, UK), an innovative software manufacturer for an undisclosed amount. Apart from state-of-the-art endoscopes, high-end medical devices, and integrated solutions for the operating room, KARL STORZ continues its expansion into innovative software solutions. The company’s wide customer base, which includes top-class physicians across the world, can now enjoy access to 3D models created from medical scans, making surgery much easier and even more successful. The know-how gained with the acquisition in the field of artificial intelligence (AI) will significantly enhance the KARL STORZ portfolio.

ISL has developed Innersight3D, a software-only product that allows surgeons to create a patient-specific 3D model from a medical CT or MRI scan. ISL labels the received scans according to different tissue types and creates an interactive 3D model. The three-dimensional representation can then be accessed and interacted with via a web link sent to the physician. Because of the more accurate preoperative assessment, benefits include for example reducing operation time and the risk of surgical complications. In comparison to competing products, ISL's AI-based algorithm can significantly reduce manual effort, lowering cost per model and time to deployment.

As part of the globally active KARL STORZ Group, ISL will now focus on commercial scaling and joint technology development. The ISL acquisition adds an AI product to the existing KARL STORZ portfolio marking the next step in its efforts to integrate AI into laparoscopic and robotic imaging solutions in the healthcare industry. KARL STORZ aims to incorporate the extensive possibilities offered by AI into the development of cutting-edge medical technology at an early stage, allowing it to offer the best instruments for patients with the highest safety standards in the market.

Related Links:
KARL STORZ
Innersight Labs Ltd.

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Ultrasound System
Voluson Signature 18

Print article

Channels

Critical Care

view channel
Image: The new risk assessment tool determines patient-specific risks of developing unfavorable outcomes with heart failure (Photo courtesy of 123RF)

Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients

Heart failure is a serious condition where the heart cannot pump sufficient blood to meet the body's needs, leading to symptoms like fatigue, weakness, and swelling in the legs and feet, and it can ultimately... Read more

Surgical Techniques

view channel
Image: The multi-sensing device can be implanted into blood vessels to help physicians deliver timely treatment (Photo courtesy of IIT)

Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health

Researchers have embarked on a project to develop a multi-sensing device that can be implanted into blood vessels like peripheral veins or arteries to monitor a range of bodily parameters and overall health status.... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more